Presence of Multiple Anti-Phospholipid Antibody Specificities in a Pediatric Population

References

• Aoki K., Hayashi Y., Hirao Y., Yagami Y. Specific antiphospholipid antibodies as a predictive variable in patients with recurrent pregnancy loss. Am. J. Reprod. Immunol. 1993; 2: 82–87
   Google Scholar
• Berard M., Boffa M. C., Karmochkin M., Aillaud M. F., Juhan-Vague I., Frances C., Cacoub P., Piette J. C., Harle J. R. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with anti-phosphatidylethanolamine antibodies. J. Lab. Clin. Med. 1993; 122: 601–605
   Google Scholar
• Branch D. W., Rote N. S., Dostal D. A., Scott J. R. Association of lupus anticoagulant with antibody against phosphatidylserine. Clin. Immunol. Immunopath. 1987; 42: 63–75
   PubMedGoogle Scholar
• Branch D. W., Scott J. R. Clinical implications of antiphospholipid antibodies: The Utah experience. Phospholipid Binding Antibodies, E. N. Harris, T. Exner, G. Hughes, R. A. Asherson, 1991; 335–353
   Google Scholar
• Caporali R., Ravelli A., Ramenghi B., Montecucco C., Martini A. Antiphospholipid antibody associated thrombosis in juvenile chronic arthritis. Arch. Dis. Child. 1992; 67: 1384–1386
   PubMed Web of Science ®Google Scholar
• Chedid A., Chadalawada K. R., Morgan T. R., Moritz I. E., Mendcnhall C. L., Hammond J. B., Emblad P. W., Cifuentes D. C., Kwak J., Gilman-Sachs A., Beaman K. D. Antiphospholipid antibodies in alcoholic liver disease. Hepatology 1994; 20: 1465–1467
   PubMed Web of Science ®Google Scholar
• Facer C. A., Agiostratidou G. High levels of antiphospholipid antibodies in uncomplicated and server Plasmodium falciparum and in P. vivax malaria. Clin. Exp. Immunol. 1994; 2: 304–309
   Google Scholar
• Galli M., Comfurius P., Maasen C., et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to plasma protein cofactor. Lancet 1990; 335: 1544–1547
   PubMed Web of Science ®Google Scholar
• Gilman-Sachs A., Lubinski J., Beer A. E., Brend S., Beaman K. D. Patterns of anti-phospholipid antibody specificities. J. Clin. Lab. Immunol. 1991; 35: 83–88
   PubMedGoogle Scholar
• Harris E. N., Gharavi A. E., Bocy M. L., et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus crythematosus. Lancet 1983; 2: 1211–1214
   PubMed Web of Science ®Google Scholar
• Harris E. N., Gharavi A. E., Hughes R. G. V. Antiphospholipid antibodies. Clin. Rheum. Dis. 1985; 11: 591–608
   PubMedGoogle Scholar
• Hughes G. R. V., Asherson R. A., Khamashta M. A. Antiphospholipid syndrome: linking many specialties. Ann. Rheum. Dis. 1989; 48: 355–356
   PubMed Web of Science ®Google Scholar
• Jaroslav Stern J., Ng R. H., Triplett D. A., McIntyre J. A. Incidence of antiphospholipid antibodies in patients with monoclonal gammopathy of undcrtermined significance. Am. J. Clin. path. 1993; 101: 471–474
   Google Scholar
• Karmochkine M., Berard M., Piette J. C., Cacoub P., Aillaud M. F., Harle J. R., Godeau P., Boffa M. C. Antiphosphatidylethanolamine antibodies in systemic lupus crythematosus. Lupus 1993; 3: 157–160
   Google Scholar
• Kucuk O., Gilman-Sachs A., Beaman K. D., Liss L. J., Westerman M. P. Antiphospholipid antibodies in sickle cell disease. Am. J. Hematol. 1993; 42: 380–383
   Google Scholar
• Kuttch W. H., Wester R., Kuttch C. C. Multiples of the median: an alternative method for reporting antiphospho-lipid antibodies in women with recurrent pregnancy loss. Ob. & Gyn. 1994; 84: 811–814
   Google Scholar
• Levine S. R., Welch K. M. A. The spectrum of neurologic disease associated with antiphospholipid antibodies. Arch. Neurol. 1987; 44: 876–883
   PubMedGoogle Scholar
• Loizou S., Mackworth-Young C. G., Conner C., Walport M. J. Heterogeneity of binding reactivity to different phospholipids of antibodies from patients with systemic lupus crythematosus (SLE) and with syphilis. Clin. Exp. Immunol. 1990; 80: 171–176
   PubMedGoogle Scholar
• Love P. E., Santoro S. A. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus crythematosus (SLE) and in non-SLE disorders. Ann. Inter. Med 1990; 112: 682–698
   PubMed Web of Science ®Google Scholar
• Mackworth-Young C. G., Loizou S., Walport M. J. Primary antiphospholipid syndrome: features of patients with raised anticardiolipin and no other disorder. Ann. Pheum. Dis. 1987; 48: 362–367
   Google Scholar
• Mc Carty-Farid G. A. Antiphospholipid antibodies in systemic lupus crythematosus and Sjogren's syndrome. Curr. Opin. Rheumatol. 1993; 5: 596–603
   Google Scholar
• McNeil H. P., Chesterman C. N., Krillis S. A. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br. J. Haemat 1989; 73: 506–1547
   PubMed Web of Science ®Google Scholar
• McNeil H. P., Simpson R. J., Chesterman C. N., Krilis S. A. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: (32 Glycoprotein I (Apolipoprotein H). Proc. Natl Acad. Sci. USA 1990; 87: 4120–4224
   PubMed Web of Science ®Google Scholar
• Triplett D. A., Brandt J. T., Musgrave K. A., Orr C. A. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA 1988; 259: 550–554
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Yoshimura S., Geshi Y., Sasamori Y., and others. Measurement of antiphospholipid antibody by ELISA using purified beta 2-glycoprotcin I in preeclampsia. Clin. Exp. Immunol. 1993; 1: 196–200
   Google Scholar